Celgene Corp /de/ (CIK 0000816284)

Latest company ownership

Shares held
7,047,489
Last filed at
Jul 13, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
3,722,534
Last filed at
Dec 7, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 9, 2020 Jul 13, 2020 BRISTOL MYERS SQUIBB CO 10% Owner Sell 47.5 -2,241 -0.03% ✗ $229.2K
Jul 1, 2020 Jul 6, 2020 BRISTOL MYERS SQUIBB CO 10% Owner Buy 88.8 +108,108 1.58% ✗ $10M
Nov 12, 2019 Nov 14, 2019 AGIOS PHARMACEUTICALS, INC. 10% Owner Buy 97.5 +403,225 6.00% ✗ $12.5M
Jan 23, 2018 Jan 31, 2018 AGIOS PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +851,154 14.51% ✗ $57M
Jan 23, 2018 Jan 23, 2018 AGIOS PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +851,154 14.51% ✗ $57M
Nov 3, 2017 Dec 7, 2017 CRISPR Therapeutics AG 10% Owner Sell 15.0 -1,112,446 -1.22% ✗ $21.1M
Apr 24, 2017 Apr 24, 2017 AGIOS PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +624,575 11.91% ✗ $30.9M
Oct 24, 2016 Oct 27, 2016 CRISPR Therapeutics AG 10% Owner Buy 100.0 +800,150 19.83% ✗ $11.2M
Oct 24, 2016 Oct 26, 2016 CRISPR Therapeutics AG 10% Owner Buy 100.0 +800,150 19.83% ✗ $11.2M